Belite Bio, Inc. (BLTE)
187.86
+9.53
(+5.34%)
USD |
NASDAQ |
Feb 06, 16:00
188.52
+0.66
(+0.35%)
After-Hours: 20:00
Belite Bio Total Liabilities (Quarterly) : 8.311M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ocugen, Inc. | 54.06M |
| Ionis Pharmaceuticals, Inc. | 2.415B |
| Ligand Pharmaceuticals, Inc. | 526.60M |
| IDEAYA Biosciences, Inc. | 93.10M |
| Terns Pharmaceuticals, Inc. | 17.58M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 282.39M |
| Shareholders Equity (Quarterly) | 274.08M |
| Debt to Equity Ratio | 0.0019 |
| Current Ratio | 34.37 |
| Net Debt Paydown Yield | -0.00% |